corporary

SERB

Active
SIREN 552005241 VAT number FR16552005241 LEI 969500SODSBHSC9OC634

Business purpose.

Toutes recherches et études susceptibles de faciliter l'exécution de tous travaux de laboratoires, d'analyses médicales et biologiques, la fabrication, l'achat et la vente de tous produits pharmaceutiques spéciaux ou non

SERB is a company registered under SIREN number 552005241, with its registered office in PARIS. Its main activity falls under the sector: Manufacture of basic pharmaceutical products and pharmaceutical preparations. It has 3 establishments. 6 serving directors are recorded in the national business register. Its reported revenue for the financial year ended in 2025 is 115,822,848 euros.

Sources: INSEE Sirene, INPI RNE, INPI, annual accounts.

Identity

Legal form
SAS, simplified joint-stock company
Activity
Manufacture of pharmaceutical preparations (21.20Z)
Sector
Manufacture of basic pharmaceutical products and pharmaceutical preparations
Headcount
50 to 99 employees
Created
25 Jul 1951
Share capital
307,142,986.96 EUR
Registered with the trade register
12 Jan 1955
Financial year end
31/12
Establishments
3

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Other companies at the same address

477 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

67 / 100 B

Confidence: high · computed on the financial year ended 31 Dec 2025

Equity to assets (70.3 %)
24.2 out of 30
EBITDA margin (19.1 %)
19.0 out of 25
Liquidity (176.7 %)
7.7 out of 20
Debt (22.6 %)
11.2 out of 15
Revenue trend (4.7 %)
4.9 out of 10

formula fin-1.0

Legal score

100 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (75.3 years)
20.0 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2018 2019 2020 2021 2022 2023 2024 2025

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2025 115,822,848 € +4.7 % 22,145,668 € 15,373,538 €
31 Dec 2024 110,579,631 € +21.4 % 17,137,177 € 2,368,702 €
31 Dec 2023 91,061,161 € +8.4 % 16,658,349 € 7,524,254 €
31 Dec 2022 83,976,529 € +17.0 % 19,360,559 € 7,191,513 €
31 Dec 2021 71,765,730 € +9.3 % 20,184,618 € 2,943,299 €
31 Dec 2020 65,669,745 € +20.5 % 24,931,267 € 16,572,946 €
31 Dec 2019 54,498,033 € +10.7 % 18,013,434 € 10,945,390 €
31 Dec 2018 49,230,881 € first year on record 15,504,896 € 9,202,380 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.

    IDCC 0176 · repealed · 1 establishment · declared in July 2026

Labels and certifications

Gender equality index

  • Gender equality index 2025

    96 out of 100

  • Gender equality index 2024

    94 out of 100

  • Gender equality index 2023

    96 out of 100

  • Gender equality index 2022

    94 out of 100

  • Gender equality index 2021

    92 out of 100

Legal notices

  • Filing of accounts 6 Aug 2026
    Court :
    Greffe du Tribunal des Activités Economiques de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2025

    BODACC C n 20260148, annonce n 18992 · Proof of publication (PDF)

  • Amendment 25 Feb 2026
    Court :
    Greffe du Tribunal des Activités Economiques de Paris
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20260038, annonce n 1679 · Proof of publication (PDF)

  • Amendment 30 Jan 2026
    Court :
    Greffe du Tribunal des Activités Economiques de Paris
    Amendment :
    modification survenue sur l'adresse du siège et l'adresse de l'établissement

    BODACC B n 20260020, annonce n 2487 · Proof of publication (PDF)

  • Amendment 27 Nov 2025
    Court :
    Greffe du Tribunal des Activités Economiques de Paris
    Amendment :
    modification survenue sur le capital (augmentation) et l'activité de l'établissement principal

    BODACC B n 20250228, annonce n 2237 · Proof of publication (PDF)

  • Filing of accounts 29 Jul 2025
    Court :
    Greffe du Tribunal des Activités Economiques de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2024

    BODACC C n 20250143, annonce n 22065 · Proof of publication (PDF)

  • Filing of accounts 25 Aug 2024
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2023

    BODACC C n 20240164, annonce n 3018 · Proof of publication (PDF)

  • Filing of accounts 17 Sep 2023
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2022

    BODACC C n 20230179, annonce n 7160 · Proof of publication (PDF)

  • Amendment 27 Jun 2023
    Court :
    Greffe du Tribunal de Commerce de Paris
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20230122, annonce n 1925 · Proof of publication (PDF)

  • Amendment 15 Nov 2022
    Court :
    Greffe du Tribunal de Commerce de Paris
    Amendment :
    modification survenue sur l'administration

    BODACC B n 20220221, annonce n 4713 · Proof of publication (PDF)

  • Filing of accounts 9 Aug 2022
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2021

    BODACC C n 20220153, annonce n 7443 · Proof of publication (PDF)

  • Amendment 19 Dec 2021
    Court :
    Greffe du Tribunal de Commerce de Paris
    Amendment :
    modification survenue sur l'administration

    BODACC B n 20210246, annonce n 1624 · Proof of publication (PDF)

  • Filing of accounts 10 Sep 2021
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2020

    BODACC C n 20210177, annonce n 3025 · Proof of publication (PDF)

  • Amendment 3 Sep 2021
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Amendment :
    modification survenue sur l'administration

    BODACC B n 20210172, annonce n 1643 · Proof of publication (PDF)

  • Filing of accounts 20 Sep 2020
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2019

    BODACC C n 20200183, annonce n 5063 · Proof of publication (PDF)

  • Amendment 24 Oct 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Amendment :
    modification survenue sur l'administration

    BODACC B n 20190206, annonce n 2683 · Proof of publication (PDF)

  • Filing of accounts 16 May 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2018

    BODACC C n 20190094, annonce n 4288 · Proof of publication (PDF)

  • Amendment 15 Feb 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20190033, annonce n 1623 · Proof of publication (PDF)

Public contracts won

158 current contracts

Source: essential public procurement data (DECP), Open Licence 2.0. Only the current version of each contract is shown.

Annual accounts as PDF →

Filings and accounts

  • Formality 14 Feb 2026
  • Formality 21 Jan 2026
  • Formality 18 Nov 2025
  • Formality 14 Oct 2025
  • Formality 16 Sep 2025

Change history

  • officer_appointed (empty) → Commissaire aux comptes titulaire 9 Oct 2026
  • officer_appointed (empty) → Commissaire aux comptes suppleant 9 Oct 2026
  • officer_appointed (empty) → President de SAS 9 Oct 2026
  • officer_appointed (empty) → Directeur general delegue 9 Oct 2026
  • officer_appointed (empty) → Directeur general delegue 9 Oct 2026
  • officer_appointed (empty) → Directeur general delegue 9 Oct 2026
  • capital 219628318.47 → 9331409.07 3 Oct 2026
  • capital 9331409.07 → 219628318.47 3 Oct 2026
  • capital 259628318.47 → 9331409.07 1 Oct 2026
  • registered_address 32 rue de Monceau 75008 Paris → 40 avenue George V 75008 Paris 1 Oct 2026
  • capital 307142986.96 → 259628318.47 1 Oct 2026
  • registered_address (empty) → 32 rue de Monceau 75008 Paris 1 Oct 2026
  • capital 259628318.47 → 307142986.96 1 Oct 2026
  • capital (empty) → 259628318.47 1 Oct 2026

Frequently asked questions about SERB

What is the SIREN number of SERB?
The SIREN number of SERB is 552005241. Its intra-community VAT number is FR16552005241.
Where is the head office of SERB?
Head office address: 32 RUE DE MONCEAU, 75008 PARIS.
When was SERB founded?
SERB was founded on 25 Jul 1951.
What does SERB do?
Its declared main activity is: Manufacture of pharmaceutical preparations (NAF code 21.20Z).
Who runs SERB?
The officers listed in the register are ANTOINE Bernasconi (Directeur general delegue), Marc Isidore HAIM (Directeur general delegue), BICH Pham Huy (Directeur general delegue).
What is the revenue of SERB?
The latest published revenue is 115,822,848 €, for the 2025 financial year.
How many employees does SERB have?
The declared headcount is 50 to 99 employees. Insee data for 2024.
Is SERB subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data